These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10762453)

  • 1. Modified LDL - trigger of atherosclerosis and inflammation in the arterial intima.
    Pentikäinen MO; Oörni K; Ala-Korpela M; Kovanen PT
    J Intern Med; 2000 Mar; 247(3):359-70. PubMed ID: 10762453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of modified oxidation of low density lipoprotein in pathognesis of atherosclerosis].
    Siennicka A; Zapolska-Downar D
    Postepy Hig Med Dosw; 2003; 57(2):219-37. PubMed ID: 12866357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis.
    Paulson KE; Zhu SN; Chen M; Nurmohamed S; Jongstra-Bilen J; Cybulsky MI
    Circ Res; 2010 Feb; 106(2):383-90. PubMed ID: 19893012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative modifications of LDL increase its binding to extracellular matrix from human aortic intima: influence of lesion development, lipoprotein lipase and calcium.
    Wang X; Greilberger J; Ratschek M; Jürgens G
    J Pathol; 2001 Sep; 195(2):244-50. PubMed ID: 11592105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol crystals piercing the arterial plaque and intima trigger local and systemic inflammation.
    Abela GS
    J Clin Lipidol; 2010; 4(3):156-64. PubMed ID: 21122648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherogenecity of lipoprotein(a) and oxidized low density lipoprotein: insight from in vivo studies of arterial wall influx, degradation and efflux.
    Nielsen LB
    Atherosclerosis; 1999 Apr; 143(2):229-43. PubMed ID: 10217351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of native and naturally occurring multiple modified low density lipoprotein in smooth muscle cells of human aortic intima.
    Tertov VV; Orekhov AN
    Exp Mol Pathol; 1997; 64(3):127-45. PubMed ID: 9439479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The extracellular matrix on atherogenesis and diabetes-associated vascular disease.
    Camejo G; Olsson U; Hurt-Camejo E; Baharamian N; Bondjers G
    Atheroscler Suppl; 2002 May; 3(1):3-9. PubMed ID: 12044579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells.
    Sobenin IA; Tertov VV; Koschinsky T; Bünting CE; Slavina ES; Dedov II; Orekhov AN
    Atherosclerosis; 1993 Apr; 100(1):41-54. PubMed ID: 8318062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipids and blood vessels].
    Drexel H; Amann FW
    Schweiz Rundsch Med Prax; 1993 Nov; 82(47):1344-7. PubMed ID: 8272699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The significance of oxidized lipoproteins for the development of atherosclerosis. Antioxidants as a therapeutic alternative in atherosclerosis].
    Boberg KM
    Tidsskr Nor Laegeforen; 1991 Jun; 111(15):1861-5. PubMed ID: 1853321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathogenesis of atherosclerosis: an overview.
    Schwartz CJ; Valente AJ; Sprague EA; Kelley JL; Nerem RM
    Clin Cardiol; 1991 Feb; 14(2 Suppl 1):I1-16. PubMed ID: 2044253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interaction of native and modified low density lipoprotein with intimal cells in atherosclerotic lesion].
    Nikoforov NG; Gratchev AN; Sobenin IA; Orekhov AN; Kzhyhskowska YG
    Patol Fiziol Eksp Ter; 2013; (1):109-17. PubMed ID: 23805724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in intima-media permeability to low-density lipoprotein at atherosclerosis-prone aortic sites in rabbits. Lack of effect of 17 beta-estradiol.
    Schwenke DC
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2150-7. PubMed ID: 9351384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of LDL in the origin and progression of atherosclerosis: pathobiological concepts on the origin and development of atherosclerotic lesions and the role of the endothelium].
    De Caterina R; Lenzi S
    G Ital Cardiol; 1998 Feb; 28(2):158-67. PubMed ID: 9534057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities.
    Bäck M; Yurdagul A; Tabas I; Öörni K; Kovanen PT
    Nat Rev Cardiol; 2019 Jul; 16(7):389-406. PubMed ID: 30846875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Why are plasmatic apoB lipoproteins atherogenic? The hypothesis of response to retention].
    Hurt-Camejo E; Camejo G
    Invest Clin; 2001 May; 42 Suppl 1():43-73. PubMed ID: 11416984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein lipase in the arterial wall: linking LDL to the arterial extracellular matrix and much more.
    Pentikäinen MO; Oksjoki R; Oörni K; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):211-7. PubMed ID: 11834518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Does modified LDL cholesterol trigger the atherosclerotic process?].
    Mölgaard J; Johansson J
    Lakartidningen; 1989 Jul; 86(28-29):2521-2. PubMed ID: 2779315
    [No Abstract]   [Full Text] [Related]  

  • 20. Marked low-density lipoprotein cholesterol reduction below current national cholesterol education program targets provides the greatest reduction in carotid atherosclerosis.
    Kent SM; Coyle LC; Flaherty PJ; Markwood TT; Taylor AJ
    Clin Cardiol; 2004 Jan; 27(1):17-21. PubMed ID: 14743850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.